ETR:FME - Fresenius Medical Care AG & Co. KGaA Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€62.12 +0.36 (+0.58 %)
(As of 01/23/2019 06:23 AM ET)
Previous Close€61.76
Today's Range€61.48 - €62.40
52-Week Range€75.53 - €93.82
Volume202,726 shs
Average Volume704,197 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FME News and Ratings via Email

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+49-6172-6090

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees112,134
OptionableNot Optionable

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What price target have analysts set for FME?

22 brokers have issued 1 year price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their forecasts range from €66.00 to €107.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's stock price to reach €84.36 in the next twelve months. This suggests a possible upside of 35.8% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co. KGaA.

What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co. KGaA?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 9 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co. KGaA.

Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage?

Press coverage about FME stock has trended positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a news sentiment score of 2.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the stock's share price in the near term.

Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €62.12.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is http://www.freseniusmedicalcare.com/.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.


MarketBeat Community Rating for Fresenius Medical Care AG & Co. KGaA (ETR FME)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  828 (Vote Outperform)
Underperform Votes:  535 (Vote Underperform)
Total Votes:  1,363
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. KGaA and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel